CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Intermountain Health

Jordan Muhlestein, Corporate Counsel

A Lens Switch for Improved Compliance Effectiveness

Jordan Muhlestein

Jordan Muhlestein

A phoropter is a medical device that you likely have seen or used but may not recognize by name. It could also be called the lots-of-lensesmachine-your-optometrist-uses, and that may make it more recognizable.


The phoropter’s purpose is to allow an eye care professional to test many vision correction lenses quickly and easily, each option getting closer to a patient’s specific prescription.


In healthcare, leaders should consider a similar concept as they seek to have an effective regulatory compliance program.


There are many lenses we can use to determine whether we are effective at identifying and mitigating regulatory risks. Each of these may be valuable to monitor as a critical performance indicator.


In healthcare, leaders should consider a similar concept as they seek to have an effective regulatory compliance program.


We can review financial performance, including the number of denied claims or the results of government audits.


We can measure the completion of compliance education or — even better — include quizzes to measure whether employees really understand the information.


We may survey our workforce to understand things like whether people know about our nonretaliation policy and whether they believe we follow it. If there is a gap between those numbers, we may have more work to do.


We may look at the number of complaints or reports we receive for various compliance risks, such as privacy, conflict of interest, or harassment.


Just like the phoropter, many lenses may be necessary to create a clear and accurate vision of how our program is really operating in practice.


One lens we should never fail to use, though, is that of what compliance means to an individual. Are we helping each of our employees be successful in their role? Are our policies and processes seen as protective, or are they seen as requirements that have a purpose but hinder efficient healthcare?


A recent statement by Christi Grimm, Inspector General for the U.S. Department of Health and Human Services, emphasizes this what’s-it-mean-in-practice lens.


“Think about an individual employee,” she said. “That employee faces an ethical dilemma that forces them to make a choice. Has your company informed, trained, and empowered that employee to make the right choice? Are they empowered to make the choice that is consistent with your mission? And in times when that employee makes the wrong choice, does your company have the right capabilities to detect it, to fix it, and to ensure others don’t do the same?”


Clinical care requires a constant focus on what is needed for each patient’s care. As healthcare leaders, we must make sure we view compliance through the lens of a particular employee. Otherwise, we may miss out on some of the most effective ways to remain compliant.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/jordan-muhlestein-nwid-2552.html